Nike and Doernbecher introduce the 2025 Doernbecher Freestyle collection, created by Doernbecher patient-designers. The 21-year-old Nike-OHSU Doernbecher Freestyle partnership has raised more than $40 million for the children's hospital.

Nike and Doernbecher introduce the 2025 Doernbecher Freestyle collection, created by Doernbecher patient-designers. The 21-year-old Nike-OHSU Doernbecher Freestyle partnership has raised more than $40 million for the children's hospital.

GRAIL PATHFINDER 2 study finds Galleri, a multi-cancer early detection blood test, increased cancer detection more than seven-fold when added to U.S. Preventive Services Task Force A and B recommended screenings; OHSU principal investigator Nima Nabavizadeh, M.D., says: “Cancer screening saves lives, but we routinely screen for just four or five cancer types in the United States today and approximately 70% of cancer deaths come from cancers that do not have standard-of-care screening and are typically caught too late. Data from PATHFINDER 2 show that Galleri could fundamentally change our approach to cancer screening, helping to detect many types of cancer earlier, when the chance of successful treatment or even cure are the greatest.”

The Portland Business Journal’s list of employers notes OHSU is the largest employer in the Portland-metro area.

An Oregonian article about Medicare Advantage enrollees facing growing uncertainty in choosing plans and keeping doctors cites OHSU’s goal of negotiating better rates from United Healthcare, Regence BlueCross Blue Shield and Kaiser Permanent, as part of the university’s strategic efforts to address its structural financial deficiency.

Kimberly Hutchison tells Men’s Fitness that the social media trend of taping your mouth shut to achieve better sleep and reduce snoring could lead to sleep apnea or cause suffocation: “The studies behind mouth tape are small, the benefits are modest, and the potential risks are there.”

In an Axios Portland article about new data that show Oregon saw the highest obesity rate increase of any state from 2019 to 2024, Diane Stadler, Ph.D., says young adults, ages 18 to 24, have been particularly affected by the pandemic’s social and mental health fallout in recent years. "It's very concerning," she said, adding that rates of depression and loneliness are higher in young populations. "It's a harbinger of what we are going to see in the future."

GRAIL PATHFINDER 2 study finds Galleri, a multi-cancer early detection blood test, increased cancer detection more than seven-fold when added to U.S. Preventive Services Task Force A and B recommended screenings; OHSU principal investigator Nima Nabavizadeh, M.D., says: “Cancer screening saves lives, but we routinely screen for just four or five cancer types in the United States today and approximately 70% of cancer deaths come from cancers that do not have standard-of-care screening and are typically caught too late. Data from PATHFINDER 2 show that Galleri could fundamentally change our approach to cancer screening, helping to detect many types of cancer earlier, when the chance of successful treatment or even cure are the greatest.”

GRAIL PATHFINDER 2 study finds Galleri, a multi-cancer early detection blood test, increased cancer detection more than seven-fold when added to U.S. Preventive Services Task Force A and B recommended screenings; OHSU principal investigator Nima Nabavizadeh, M.D., says: “Cancer screening saves lives, but we routinely screen for just four or five cancer types in the United States today and approximately 70% of cancer deaths come from cancers that do not have standard-of-care screening and are typically caught too late. Data from PATHFINDER 2 show that Galleri could fundamentally change our approach to cancer screening, helping to detect many types of cancer earlier, when the chance of successful treatment or even cure are the greatest.”

GRAIL PATHFINDER 2 study finds Galleri, a multi-cancer early detection blood test, increased cancer detection more than seven-fold when added to U.S. Preventive Services Task Force A and B recommended screenings; OHSU principal investigator Nima Nabavizadeh, M.D., says: “Cancer screening saves lives, but we routinely screen for just four or five cancer types in the United States today and approximately 70% of cancer deaths come from cancers that do not have standard-of-care screening and are typically caught too late. Data from PATHFINDER 2 show that Galleri could fundamentally change our approach to cancer screening, helping to detect many types of cancer earlier, when the chance of successful treatment or even cure are the greatest.”